de Magalhães, João Pedro http://orcid.org/0000-0002-6363-2465
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council (BB/R014949/1)
Longevity Impetus Grants
Article History
Received: 19 June 2023
Accepted: 28 November 2023
First Online: 19 January 2024
Competing interests
: J.P.d.M. is the CSO of YouthBio Therapeutics, a company developing rejuvenation gene therapies based on partial reprogramming, an advisor or consultant for the Longevity Vision Fund, 199 Biotechnologies and NOVOS and the founder of Magellan Science, a company providing consulting services in longevity science.